how were glp 1 agonists discovered A Closer Look at the Dermatological Profile of GLP-1 Machine-Learning-Guided Peptide Drug Discovery: Development
Description
Obes Rev
The diurnal periods, e.g
Kim KS, Jung Yang H, Lee IS, Kim KH, Park J, Jeong HS, et al
ELIXA trial included patients with recent cardiovascular event (patients with acute coronary syndrome 180 days before randomization), and although there was no benefit in MACE reduction in lixisenatide treated patients compared to placebo, results revealed cardiovascular safety of lixisenatide in this specific high risk population (38, 40)
Abdominal fat particularly raises the risk of insulin resistance
What are bellwether trials
